Press release

Press Release

Cision PR Newswire2 weeks ago
0

Everlight Solar Wins Comparably’s Best Compensation Award for 2025

VERONA, Wis., Dec. 12, 2025 /PRNewswire/ — Everlight Solar announces its recognition with Comparably‘s 2025 Best Compensation Award. This distinction…
Read More »
Press Release

Cision PR Newswire2 weeks ago
0

Introducing CASEKOO Rouge. The Gold Standard.

NEW YORK, Dec. 12, 2025 /PRNewswire/ — Just in time for the season of giving, CASEKOO, the iF award-winning designer of…
Read More »
Business Wire2 weeks ago

Securities Fraud Investigation Into Fermi Inc. (FRMI) Announced – Investors Who Lost Money Urged to Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm

LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced…
Read More »
Business Wire2 weeks ago

OFS Credit Company Provides November 2025 Net Asset Value Update

CHICAGO–(BUSINESS WIRE)–OFS Credit Company, Inc. (Nasdaq: OCCI) (“OFS Credit”, the “Company”, “we”, “us” or “our”), an investment company that primarily…
Read More »
Press Release

Cision PR Newswire2 weeks ago
0

TELUS Announces Pricing of Cash Tender Offers for Seven Series of Debt Securities

VANCOUVER, BC, Dec. 12, 2025 /CNW/ – TELUS Corporation (“TELUS” or “the “Company“) announced today the pricing terms of its…
Read More »
Press Release

Cision PR Newswire2 weeks ago
0

GoodLeap Announces Closing of $523 Million Securitization Bringing the Company’s Total to 24

The transaction was the fourth securitization backed solely by GoodLeap originated home improvement loans. SAN FRANCISCO, Dec. 12, 2025 /PRNewswire/…
Read More »
Business Wire2 weeks ago

Non-Opioid Therapeutics Market Insights, Shares and Growth Outlook 2025-2032: Rising Integration of Non-Opioid Options in Multimodal Pain Management Protocols – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Non-Opioid Therapeutics Market – Global Forecast 2025-2032” has been added to ResearchAndMarkets.com’s offering. This market research report focuses…
Read More »
Business Wire2 weeks ago

U.S. FDA Approves NUZOLVENCE® (zoliflodacin), a First-in-Class, Single-dose, Oral Antibiotic for the Treatment of Uncomplicated Urogenital Gonorrhea in Adults and Adolescents

FDA approval was based on results from the largest Phase 3 clinical trial ever conducted for a new treatment against…
Read More »
Business Wire2 weeks ago

Bausch + Lomb Announces Refinancing of Outstanding Term B Loans

VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “company”), a leading global eye health company…
Read More »
Business Wire2 weeks ago

Enveric Biosciences Announces Closing of Exercise of Warrants for $3.1 Million Gross Proceeds

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation neuroplastogenic small molecules to…
Read More »

Previous page Next page